Navigation Links
Cancer Care of Western New York Becomes First Center in Western New York to Treat Cancer with RapidArc(TM) Radiotherapy Technology from Varian Medical Systems
Date:11/6/2008

can tell you, I would not like to have to lay there immobilized on a table for 30 minutes each day instead of ten."

Dr. Shah's clinical team compared a RapidArc treatment plan with one for conventional IMRT and found that the RapidArc plan spared more of Kelver's salivary glands and the rest of his oral cavity. "Prior forms of radiation therapy might have severely compromised his salivary function, which can lead to a permanent and severe dry mouth condition that would have affected his eating, digestion, taste, and dental health," Dr. Shah said. "With the RapidArc treatment, we'll have a good chance of avoiding or minimizing these kinds of debilitating side effects."

"I've finished seven treatment sessions out of 33. I have a ways to go, but so far, I'm eating and drinking fine; there's been no impact in that respect," Kelver said. "Today, I pulled the patio furniture in and worked in the yard, because we're expecting snow tonight. I plan to continue working while I'm in treatment, because it's a great distraction.

According to Dr. Shah, RapidArc technology is now being used to treat prostate, lung, and brain cancer. "A father and son, 76 and 43 years of age, are among the patients currently undergoing RapidArc treatment for prostate cancer," he said. "We looked at RapidArc plans as compared with conventional IMRT for these types of cases, and concluded that the RapidArc approach does a better job of protecting the rectum and the bladder. And with treatments being completed so quickly, these two can get in and out of the office faster and spend more quality time together."

Another patient, Raymond Kelly, is a 72-year-old man with stage 3 lung cancer that has spread to his lymph nodes on both sides. "With earlier forms of radiation therapy, once a tumor spreads to this degree, you have to limit the dose because of all the healthy lung tissue you would otherwise damage during treatment," Dr. Shah explained. "The RapidArc treatment plan doe
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHCC(R) is Safe in Combination With Most Chemotherapeutic Agents
2. Bradmer sponsors physician panel to raise awareness of brain cancer treatments
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) Centennial Conference
4. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
5. Data Presented at Cancer Molecular Markers Meeting Suggests Clinical Benefit for Integrating New Molecular Tests
6. Breast Cancer Patients Take DNA Test to Determine Best Treatment
7. Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
8. Rexin-G Returns to The Big Apple: Clinical Trials for Pancreatic Cancer and Breast Cancer Open in Manhattan
9. Singapore Medicine - Breakthrough Development of Cell Therapy Treatment for Cancer
10. AstraZeneca and M. D. Anderson Renew Cancer Research Collaboration
11. Japanese Cancer Association and Debiopharm Honour Japanese Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Look inside the new Preferred ... the lab, from fluid handling to instruments to supplies. ... when you order. , Preferred Solutions features a ... the L/S® model for precise flow control and dispensing ...
(Date:1/15/2014)... Canada (PRWEB) January 15, 2014 This ... on nonclinical and clinical safety assessment in biosimilars. , ... path for biosimilar drug development, however the complex nature ... to quality, safety and efficacy extremely challenging. Based on ...
(Date:1/15/2014)... Rochester, NY (PRWEB) January 15, 2014 The ... cause a major disease. One of these latent viruses is ... is rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... the theory, a study found that RA patients have high ...
(Date:1/15/2014)... Toronto, ON (PRWEB) January 15, 2014 ... an experimental new therapy for the treatment of tinnitus. ... unique tinnitus frequency, and over a period of weeks to ... Notched Sound Therapy in two forms: Notched Music and Notched ...
Breaking Biology Technology:Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... SAN FRANCISCO, Calif., Aug. 27 Poniard,Pharmaceuticals, Inc. ... oncology, today announced that Jerry McMahon, Ph.D., chairman ... September during which he,will provide a corporate overview, ... picoplatin, the Company,s lead product candidate., -- ...
... and MILPITAS, California, August 27, Peakdale Molecular ... chemistry services to the pharmaceutical and,biotechnology industry, ... unique,and cost-effective provider of products and systems ... of AssayReady4U(TM)., AssayReady4U(TM) is an online ...
... INDIANAPOLIS, Aug. 26 Amylin,Pharmaceuticals, Inc. (Nasdaq: AMLN ... ),in a conference call today provided context and additional ... Administration (FDA),update to a prior alert for BYETTA(R) (exenatide) ... cases referenced,in the alert, as well as others, and ...
Cached Biology Technology:Poniard Pharmaceuticals Announces Upcoming Conference Participation 2Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC 2Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC 3Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 2Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 3Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 4Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 5Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA 6
(Date:4/17/2014)... KAN. A Kansas State University engineer has ... and remotely detects improvised explosive devices. The same ... William Dunn, the Steven M. and Kay L. ... mechanical and nuclear engineering, and his research team ... hidden underground or in car trunks. The distance ...
(Date:4/17/2014)... professor Rajendra Singh Thursday as a "Champion of ... solar deployment in the residential, commercial and industrial ... of Electrical and Computer Engineering and director of ... local hero leading the charge across the country ... power and driving policy changes at the local ...
(Date:4/17/2014)... the Amazon help create tinderbox conditions for wildfires ... forest loss during drought years, according to a ... in the Amazon could reach a "tipping point" ... to large-scale loss of trees, making recovery more ... Penn State. , "We documented one of the ...
Breaking Biology News(10 mins):Patented research remotely detects nitrogen-rich explosives 2White House honors Clemson professor as 'Champion of Change' for solar deployment 2Drought and fire in the Amazon lead to sharp increases in forest tree mortality 2Drought and fire in the Amazon lead to sharp increases in forest tree mortality 3
... could also be giving us bad breath, according to research ... Medical Microbiology . For the first time, scientists have found ... who are not showing signs of stomach disease. The ... some of which can cause disease. Helicobacter pylori ...
... set of proteins known as cannabinoid receptors, which ... body also has chemicals known as endocannabinoids that ... (AEA) and 2-arachidonoylglycerol (2-AG). These natural components of ... efforts to develop new treatments not only for ...
... Buenos Aires, Argentina Current research suggests that melatonin ... disease. The related report by Sande et al., "Therapeutic ... December issue of The American Journal of Pathology ... pain in their eyes, and their vision rapidly deteriorates. ...
Cached Biology News:Stomach ulcer bug causes bad breath 2Scripps research team defines new painkilling chemical pathway 2Melatonin may save eyesight in inflammatory disease 2
Chicken polyclonal to ADI1 ( Abpromise for all tested applications). Antigen: Full length native protein (purified), corresponding to amino acids 1-179 of Human ADI1. Entrez GeneID: 55256 ...
anti-JNK2 Immunogen: Recombinant human JNK2 protein Accession Number: NM_002752 Quality Assurance: Routinely evaluated by immunoblot. Molecular Weight: 46 and/or 54 kDa Available ...
Gloves are 9.25 long, latex, powder free, smooth and ambidextrous....
Request Info...
Biology Products: